Tags

Type your tag names separated by a space and hit enter

Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.
J Infect Dev Ctries. 2020 02 29; 14(2):125-128.JI

Abstract

As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease.

Authors+Show Affiliations

Freelance Journalist, JIDC Italy. rporcheddu@jidc.org.Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy. cserra@uniss.it.JIDC-Canada; Department of Microbiology and Immunology, Canadian Center for Vaccinology, Dalhousie University, Halifax, NS, Canada. International Institute of Infection and Immunity, Shantou, China. dkelvin@jidc.org.JIDC-Canada, Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada. nkelvin@jidc.org.Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy. srubino@jidc.org.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32146445

Citation

Porcheddu, Rossella, et al. "Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China." Journal of Infection in Developing Countries, vol. 14, no. 2, 2020, pp. 125-128.
Porcheddu R, Serra C, Kelvin D, et al. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020;14(2):125-128.
Porcheddu, R., Serra, C., Kelvin, D., Kelvin, N., & Rubino, S. (2020). Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. Journal of Infection in Developing Countries, 14(2), 125-128. https://doi.org/10.3855/jidc.12600
Porcheddu R, et al. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020 02 29;14(2):125-128. PubMed PMID: 32146445.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. AU - Porcheddu,Rossella, AU - Serra,Caterina, AU - Kelvin,David, AU - Kelvin,Nikki, AU - Rubino,Salvatore, Y1 - 2020/02/29/ PY - 2020/02/28/received PY - 2020/02/29/accepted PY - 2020/3/9/entrez PY - 2020/3/9/pubmed PY - 2020/3/19/medline KW - Case Fatality Rates KW - Italy KW - Novel coronavirus COVID-19 KW - SARS-CoV-19 KW - outbreak SP - 125 EP - 128 JF - Journal of infection in developing countries JO - J Infect Dev Ctries VL - 14 IS - 2 N2 - As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease. SN - 1972-2680 UR - https://www.unboundmedicine.com/medline/citation/32146445/Similarity_in_Case_Fatality_Rates__CFR__of_COVID_19/SARS_COV_2_in_Italy_and_China_ L2 - http://www.jidc.org/index.php/journal/article/view/32146445 DB - PRIME DP - Unbound Medicine ER -